Vergoeding 2018-2022 voor ATC-subgroep B01AF : Directe remmers van factor xa
- Raming voor de totale Zvw-populatie
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
B01AF01 Rivaroxaban (Xarelto ®) | 61.255.400 | 79.582.800 | 91.620.800 | 100.546.900 | 111.884.900 |
B01AF02 Apixaban (Eliquis ®) | 46.041.300 | 61.322.600 | 76.708.900 | 93.343.000 | 113.391.300 |
B01AF03 Edoxaban (Lixiana ®) | 11.379.000 | 17.800.500 | 23.596.200 | 27.756.200 | 32.172.500 |
Totaal | 118.675.700 | 158.705.900 | 191.925.900 | 221.646.100 | 257.448.700 |